California v. Texas: The Fate of the Affordable Care Act

California v. Texas: The Fate of the Affordable Care Act

Legal Sidebari

California v. Texas: The Fate of the Affordable
Care Act
October 27, 2020
On November 10, 2020, the Supreme Court is scheduled to hear oral argument in California v. Texas
(consolidated with the related case Texas v. California), a constitutional challenge to the Affordable Care
Act’s (ACA’s) individual mandate. The suit also seeks to invalidate the ACA’s many other provisions,
which cover a range of issues such as the regulation of private health insurance, changes to public health
care programs like Medicaid and Medicare, funding for preventive health care programs, drug regulation,
and nutritional content display at restaurants. This Sidebar provides background on the ACA’s individual
mandate, including relevant prior litigation, followed by a discussion of the California v. Texas case,
including the parties’ arguments in the case. It concludes with some select considerations for Congress.
The ACA’s Individual Mandate
Enacted in 2010, one of the ACA’s central goals was to “increase the number and share of Americans
who are insured.” In its original form, the ACA’s major components included sweeping changes to
federal regulation of private health insurance, established income-based subsidies to facilitate the
purchase of health insurance, and substantially increased the scope of Medicaid coverage. Additionally, in
a requirement commonly referred to as the individual mandate, the law compelled certain individuals to
maintain minimum levels of health insurance and, as originally enacted, imposed financial penalties
enforced as a tax on those who failed to comply with the requirement.
The Supreme Court has once before considered the individual mandate’s constitutionality. In 2012, the
Court addressed this issue in its landmark case, National Federation of Independent Business (NFIB) v.
Sebelius. In NFIB, several states and private litigants argued that the individual mandate exceeded
Congress’s legislative authority. They further claimed the rest of the ACA was not severable from the
individual mandate and would thereby have to be invalidated in its entirety if the individual mandate was
held unconstitutional. Chief Justice Roberts, writing for himself, was joined by Justices Scalia, Kennedy,
Thomas, and Alito, writing separately, in ruling that neither Congress’s authority to regulate interstate
commerce nor its derivative authority to enact necessary laws to effectuate its enumerated powers gave
Congress authority to enact the individual mandate. These Justices collectively explained that while the
Commerce Clause allows Congress to regulate existing commercial activity, it does not bestow Congress
with the authority to compel individuals to participate in commerce. A different group of five Justices,
Congressional Research Service
https://crsreports.congress.gov
LSB10547
CRS Legal Sidebar
Prepared for Members and
Committees of Congress

Congressional Research Service
2
comprised of the Chief Justice and Justices Ginsburg, Breyer, Sotomayor, and Kagan, concluded that the
individual mandate could “reasonably be characterized” as a valid exercise of Congress’s power to levy
taxes. In his controlling opinion, the Chief Justice stated that it was “fairly possible” to view the penalty
as a tax, especially because it possessed “the essential feature of any tax: it produces at least some
revenue for the Government.” Because the individual mandate could be plausibly construed as a tax
falling within Congress’s authority under Article I to impose taxes, a Court majority upheld the individual
mandate.
Background of California v. Texas
The individual mandate that the Supreme Court is to consider in 2020 is not the same as the provision the
Court upheld in 2012. Specifically, in 2017, Congress passed major tax reform legislation (2017 tax
revision), which reduced the amount of the financial penalty for failing to comply with the individual
mandate to $0. However, due to procedural restrictions associated with the way that the 2017 tax revision
was passed, the actual provision stating that “[a]n applicable individual shall . . . ensure that the
individual, and any dependent of the individual who is an applicable individual, is covered under
minimum essential coverage for such month” remains in federal law.
After the 2017 tax revision, several states and individuals (plaintiffs) sued the U.S. Department of Health
and Human Services and the Internal Revenue Service (federal defendants) challenging the
constitutionality of the amended individual mandate. The plaintiffs argued that the individual mandate
could no longer be reasonably characterized as a tax because it could not raise revenue with a financial
penalty of $0. The plaintiffs further argued that the individual mandate could not be severed from the rest
of the ACA, so the entire statute should be invalidated. The federal defendants did not contest the
plaintiffs’ argument regarding the individual mandate’s constitutionality, arguing instead that the rest of
the ACA (save a handful of private health insurance provisions—guaranteed issue and community rating
provisions or GICR) could be severed from the individual mandate and remain good law. A separate
group of states joined the litigation as intervenors (state-intervenors) to argue, among other things, that
the amended individual mandate remained constitutional and the rest of the ACA was entirely severable.
The district court issued an injunction in the plaintiffs’ favor, including ruling that the individual mandate
was not severable, but stayed its effect pending appeal.
On appeal to the U.S. Court of Appeals for the Fifth Circuit, the federal defendants modified their
position on severability, now agreeing with the plaintiffs that the entire ACA should fall with the
individual mandate. The U.S. House of Representatives joined as an intervenor defending the ACA. A
divided panel of the Fifth Circuit affirmed the district court’s determination as to the individual mandate’s
unconstitutionality. However, the majority held that the district court’s decision invalidating the entire
ACA improperly relied on Congress’s 2010 labeling of the mandate as “essential” and did not sufficiently
explain “how particular portions of the ACA as it exists post-2017 rise or fall on the constitutionality of
the individual mandate.” Thus, the Fifth Circuit remanded the severability issue to the district court to
conduct “a more searching inquiry” as to which ACA provisions as it currently exists fall with the
individual mandate.

Congressional Research Service
3
The plaintiffs and state-intervenors sought Supreme Court review of the Fifth Circuit’s decision. On
March 2, 2020, the Supreme Court granted certiorari to consider, among other things, whether the
amended individual mandate still falls within Congress’s legislative authority, and, if not, whether the
remainder of the ACA can be severed from the individual mandate or must fall with it.
Arguments in California v. Texas
Constitutionality of the Individual Mandate
Debate surrounding the amended individual mandate’s constitutionality largely centers on how to
characterize the provision following the elimination of the financial penalty in the 2017 tax revision.
Without the possibility of revenue from a financial penalty, the Fifth Circuit concluded it is “no longer
fairly possible to save the mandate’s constitutionality under Congress’ taxing power,” and said the
amended individual mandate can only be viewed as a “command to purchase insurance.” Because NFIB
held that such a command was not authorized under the Constitution’s Interstate Commerce or Necessary
and Proper Clauses, the Fifth Circuit ruled the amended individual mandate unconstitutional. This
argument is echoed by the plaintiffs and the federal defendants in California v. Texas.
By contrast, the dissenting judge on the Fifth Circuit panel argued that the elimination of the financial
penalty means the individual mandate now “does not do anything or bind anyone,” and Congress does not
“exceed[] its enumerated powers when it passes a law that does nothing.” Adopting a similar
characterization, the state-intervenors and the House of Representatives argue that the amended individual
mandate “may exhort Americans to buy health insurance, but it does not command them to do anything.”
As a precatory provision without any “possible form of compulsion,” the individual mandate cannot
compel an individual to purchase an unwanted product, obviating any concerns under the Commerce
Clause. In response, the federal defendants and plaintiffs argue that such a characterization is inconsistent
with the amended individual mandate’s text, which speaks in mandatory terms, stating that applicable
individuals “shall” maintain minimum essential coverage.
The Court’s fractured opinions in NFIB may provide some insight into how the current sitting Justices
may view the amended mandate’s constitutionality. Justices Breyer, Sotomayor, and Kagan would have
upheld the pre-2017 individual mandate under the Commerce Clause as well as the Taxing Power, which
may be suggestive of their current views. Of the remaining Justices, three more have previously written
opinions addressing the constitutionality of the original individual mandate. Justices Thomas and Alito
coauthored a dissenting opinion in NFIB arguing that the individual mandate was unconstitutional under
either the Commerce Clause or Taxing Power, and Chief Justice Roberts wrote an opinion holding that the
individual mandate was not authorized by the Commerce Clause.
Severability
Should the Supreme Court hold the amended individual mandate unconstitutional, the Court would then
turn to the question of whether the ACA’s remaining provisions are severable. Under the doctrine of
severability, the Court applies a presumption that the remainder of a law is severable from an
unconstitutional component if the remainder can operate in a manner consistent with Congress’s intent,
and absent evidence Congress would not have enacted the remaining provisions without the
unconstitutional portion. Unless the presumption is rebutted, the unconstitutional provision is severed
from the remainder of the statute. If Congress includes a severability or nonseverability clause, courts
follow those directives absent extraordinary circumstances.
The plaintiffs and federal defendants argue that the individual mandate cannot be severed from the rest of
the ACA. Following the framework used by the dissenting Justices in NFIB, the plaintiffs divide the
ACA’s provisions into three categories: (1) the GICR provisions; (2) the ACA’s major provisions, such as

Congressional Research Service
4
the health insurance subsidies and Medicaid expansion; and (3) the ACA’s minor provisions. The
plaintiffs argue that congressional findings enacted as part of the ACA clearly establish that the GICR
provisions are so closely intertwined with the individual mandate that they cannot function in the intended
manner without the mandate. The plaintiffs argue that these findings should be viewed as equivalent to a
nonseverability clause that is determinative of whether the GICR provisions can be severed from the
individual mandate. With respect to the ACA’s major provisions, they further argue that these provisions
are inseverable from the individual mandate because they work together to balance the economic effects
of “a single, coherent policy” to “effectuate the near-universal healthcare coverage that the mandate
requires.” Because the removal of the mandate would fundamentally alter that balance, the plaintiffs
argue the major provisions would no longer operate in the same manner intended by Congress. Finally,
the plaintiffs assert that the ACA’s minor provisions should fall because Congress would not have enacted
them without ACA’s major provisions.
For their part, the state-intervenors and the House of Representatives argue that the individual mandate
should be severed from the rest of the ACA. They argue that by “declaw[ing]” the individual mandate as
part of the 2017 tax revision, Congress demonstrated its intent that the ACA remain in place absent the
individual mandate. They further argue that this conclusion regarding congressional intent is bolstered by
the fact that multiple legislative attempts to repeal or substantially amend the ACA were rejected by the
115th Congress. And they note that “[r]eal-world experience since 2017” has demonstrated that the GICR
provisions continue to function without an enforceable individual mandate. In light of the legislative
context and recent programmatic experience, the state-intervenors and the House of Representatives argue
that the plaintiffs have not rebutted the presumption of severability.
Notably, several recent opinions indicate some Justices’ concerns about modern severability doctrine and
suggest a potential third option to the severability analysis. In 2018, in Murphy v. National Collegiate
Athletic Ass’n, the Court was confronted with whether to sever an unconstitutional provision from the
remainder of the Professional and Amateur Sports Protection Act, ultimately concluding that none of the
Act was severable. In a concurring opinion, Justice Thomas wrote to express his “growing discomfort
with our modern severability precedents,” suggesting this doctrine should be reevaluated “in a future
case.” Subsequently, in 2020, Justices Thomas and Gorsuch wrote separate opinions in Seila Law, LLC v.
Consumer Financial Protection Bureau and Barr v. American Ass’n of Political Consultants, respectively,
expressing similar concerns about modern severability doctrine. The three opinions generally argue that
the power of judicial review does not allow courts to revise statutes. Instead, Justices Thomas and
Gorsuch argue that a judicial remedy should be limited to an injunction preventing enforcement of an
unconstitutional provision against a plaintiff, so as to avoid rendering advisory opinions or circumventing
Article III standing requirements. Although these views reflect a minority of the Court, they suggest an
option other than conducting a traditional severability analysis, in favor of a simple injunction barring
enforcement of the amended individual mandate against the plaintiffs, assuming it is ruled
unconstitutional.
Considerations for Congress
If the individual mandate is held unconstitutional and not severable, the invalidation of the entire ACA
would have significant consequences for private insurance markets, public health care programs, and
many other areas. Perhaps because of the stakes in this case, the Court has permitted the House of
Representatives to participate in oral arguments alongside the other parties. The time allotted for oral
argument has been extended to a total of 90 minutes to accommodate the many different parties, with 30
minutes for the state-intervenors, 10 minutes for the House of Representatives, and 20 minutes each for
the federal defendants and state plaintiffs. In addition to participating in the litigation, Congress has a
variety of legislative options to address the central legal issues in California v. Texas. Congress could, for
example, repeal the individual mandate in its entirety to render the litigation moot or restore the financial

Congressional Research Service
5
penalty to the individual mandate so that it is indistinguishable from the version previously upheld in
NFIB. Congress could also enact legislation explicitly addressing the severability or nonseverability of the
individual mandate from the rest of the ACA to guide the Court’s analysis.

Author Information

Edward C. Liu

Legislative Attorney

Disclaimer
This document was prepared by the Congressional Research Service (CRS). CRS serves as nonpartisan shared staff
to congressional committees and Members of Congress. It operates solely at the behest of and under the direction of
Congress. Information in a CRS Report should not be relied upon for purposes other than public understanding of
information that has been provided by CRS to Members of Congress in connection with CRS’s institutional role.
CRS Reports, as a work of the United States Government, are not subject to copyright protection in the United
States. Any CRS Report may be reproduced and distributed in its entirety without permission from CRS. However,
as a CRS Report may include copyrighted images or material from a third party, you may need to obtain the
permission of the copyright holder if you wish to copy or otherwise use copyrighted material.

LSB10547 · VERSION 1 · NEW